Christopher P. Locher
Maxygen Inc
Division of Infectious Diseases
200 Penobscot Drive
Redwood City
USA
Name/email consistency: high
- DNA shuffling and screening strategies for improving vaccine efficacy. Locher, C.P., Paidhungat, M., Whalen, R.G., Punnonen, J. DNA Cell Biol. (2005)
- Evaluation of genetic immunization adjuvants to improve the effectiveness of a human immunodeficiency virus type 2 (HIV-2) envelope DNA vaccine. Locher, C.P., Witt, S.A., Ashlock, B.M., Levy, J.A. DNA Cell Biol. (2004)
- Development of novel vaccines using DNA shuffling and screening strategies. Locher, C.P., Soong, N.W., Whalen, R.G., Punnonen, J. Curr. Opin. Mol. Ther. (2004)
- Overcoming antigenic diversity and improving vaccines using DNA shuffling and screening technologies. Locher, C.P., Heinrichs, V., Apt, D., Whalen, R.G. Expert. Opin. Biol. Ther (2004)
- 5HT1A serotonin receptor agonists inhibit Plasmodium falciparum by blocking a membrane channel. Locher, C.P., Ruben, P.C., Gut, J., Rosenthal, P.J. Antimicrob. Agents Chemother. (2003)
- Enhancement of a human immunodeficiency virus env DNA vaccine using a novel polycationic nanoparticle formulation. Locher, C.P., Putnam, D., Langer, R., Witt, S.A., Ashlock, B.M., Levy, J.A. Immunol. Lett. (2003)
- Enhancement of antibody responses to an HIV-2 DNA envelope vaccine using an expression vector containing a constitutive transport element. Locher, C.P., Witt, S.A., Ashlock, B.M., Levy, J.A. DNA Cell Biol. (2002)
- Immune responses in baboons vaccinated with HIV-2 genetic expression libraries. Locher, C.P., Sykes, K.F., Blackbourn, D.J., Johnston, S.A. J. Med. Primatol. (2002)